American Academy of Child and Adolescent Psychiatry
The American Academy of Child and Adolescent Psychiatry (AACAP) is a 501(c)(3) non-profit professional association in the United States dedicated to facilitating psychiatric care for children and adolescents. The Academy is headquartered in Washington, D.C. Various levels of membership are available to physicians specialized in child psychiatry or pediatrics, as well as medical students interested in the field, in the United States and abroad.
|Gabrielle "Gaye" Carlson, M.D.|
Since 1962, the AACAP has published its monthly journal, Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP). There have been concerns about industry-sponsored clinical trials published in the journal. JAACAP editors have repeatedly declined to retract the journal's 2001 article on study 329, a clinical trial examining paroxetine and teenagers. The trial was sponsored by, and ghostwritten on behalf of, SmithKline Beecham (now GlaxoSmithKline), and is widely regarded as having downplayed the trial's negative results.
- AACAP Annual Report, retrieved May 12, at AACAP.org
- "About Us". AACAP. Archived from the original on 21 April 2011. Retrieved 25 March 2011.
- "Contact Us". Archived from the original on 21 April 2011. Retrieved 25 March 2011.
- "Who can become a member?". AACAP. Retrieved 25 March 2011.
- Barthel, RP (2007), "The American Academy of Child and Adolescent Psychiatry", Academic Psychiatry, 31 (2): 119–121, doi:10.1176/appi.ap.31.2.119, PMID 17344448.
- Isabel Heck, "Controversial Paxil paper still under fire 13 years later", The Brown Daily Herald, 2 April 2014.
- Newman, Melanie (2010). "The Rules of Retraction". BMJ. 341 (7785): 1246–1248. doi:10.1136/bmj.c6985. JSTOR 20800711. PMID 21138994.